Mostra 1 - 8 risultati di 8 ricerca 'Osnat Bairey', tempo di risposta: 0,03s
Raffina i risultati
-
1
Resveratrol Enhances mRNA and siRNA Lipid Nanoparticles Primary CLL Cell Transfection di Edo Kon, Inbal Hazan-Halevy, Daniel Rosenblum, Niv Cohen, Sushmita Chatterjee, Nuphar Veiga, Pia Raanani, Osnat Bairey, Ohad Benjamini, Arnon Nagler, Dan Peer
Pubblicazione 2020-06-01
Articolo -
2
Survival adjusting for crossover: phase 3 study of ibrutinib vs. chlorambucil in older patients with untreated chronic lymphocytic leukemia/small lymphocytic lymphoma di Steven Coutre, Alessandra Tedeschi, Tadeusz Robak, Paul M. Barr, Carolyn Owen, Osnat Bairey, Jan Burger, Cathy Zhou, Lori Styles, Danelle F. James, Thomas J. Kipps
Pubblicazione 2018-06-01
Articolo -
3
Efficacy and safety of front-line therapy with fludarabine-cyclophosphamide-rituximab regimen for chronic lymphocytic leukemia outside clinical trials: the Israeli CLL Study Group... di Yair Herishanu, Neta Goldschmidt, Osnat Bairey, Rosa Ruchlemer, Riva Fineman, Naomi Rahimi-Levene, Lev Shvidel, Tamar Tadmor, Aviv Ariel, Andrea Braester, Mika Shapiro, Erel Joffe, Aaron Polliack, on behalf of the Israeli CLL Study Group
Pubblicazione 2015-05-01
Articolo -
4
Safety and efficacy of the BNT162b mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia di Ohad Benjamini, Lior Rokach, Gilad Itchaki, Andrei Braester, Lev Shvidel, Neta Goldschmidt, Shirley Shapira, Najib Dally, Abraham Avigdor, Galia Rahav, Yaniv Lustig, Shirley Shapiro Ben David, Riva Fineman, Alona Paz, Osnat Bairey, Aaron Polliack, Ilana Levy, Tamar Tadmor
Pubblicazione 2021-07-01
Articolo -
5
A cross-trial comparison of single-agent ibrutinib versus chlorambucil-obinutuzumab in previously untreated patients with chronic lymphocytic leukemia or small lymphocytic lymphoma di Alessandra Tedeschi, Richard Greil, Fatih Demirkan, Tadeusz Robak, Carol Moreno, Paul M. Barr, Bertrand Anz, David Simpson, Gianluca Gaidano, Osnat Bairey, Don Stevens, Devinder Gill, Ian W. Flinn, Thomas J. Kipps, Jan A. Burger, Jennifer Lin, Thomas Webb, Viktor Fedorov, Lori Styles, John G. Gribben
Pubblicazione 2020-04-01
Articolo -
6
Sustained efficacy and detailed clinical follow-up of first-line ibrutinib treatment in older patients with chronic lymphocytic leukemia: extended phase 3 results from RESONATE-2 di Paul M. Barr, Tadeusz Robak, Carolyn Owen, Alessandra Tedeschi, Osnat Bairey, Nancy L. Bartlett, Jan A. Burger, Peter Hillmen, Steven Coutre, Stephen Devereux, Sebastian Grosicki, Helen McCarthy, Jianyong Li, David Simpson, Fritz Offner, Carol Moreno, Cathy Zhou, Lori Styles, Danelle James, Thomas J. Kipps, Paolo Ghia
Pubblicazione 2018-09-01
Articolo -
7
Variations in clinical presentation, frequency of hemophagocytosis and clinical behavior of intravascular lymphoma diagnosed in different geographical regions di Andrés J.M. Ferreri, Giuseppina P. Dognini, Elías Campo, Rein Willemze, John F. Seymour, Osnat Bairey, Maurizio Martelli, Amalia De Renzo, Claudio Doglioni, Carlos Montalbán, Alberto Tedeschi, Astrid Pavlovsky, Sue Morgan, Lilj Uziel, Massimo Ferracci, Stefano Ascani, Umberto Gianelli, Carlo Patriarca, Fabio Facchetti, Alessio Dalla Libera, Barbara Pertoldi, Barbara Horváth, Arpad Szomor, Emanuele Zucca, Franco Cavalli, Maurilio Ponzoni, on behalf of the International Extranodal Lymphoma Study Group (IELSG)
Pubblicazione 2007-04-01
Articolo -
8
P1122: A PROSPECTIVE, NON-INTERVENTIONAL STUDY OF REAL-WORLD TREATMENT AND OUTCOME IN SECONDARY CNS LYMPHOMA di Stefan Habringer, Uta Demel, Anne-Katrin Fietz, Felicitas Lammer, Roland Schroers, Silvia Hofer, Osnat Bairey, Jan Braess, Anna Sofia Meier-Stiegen, Reingard Stuhlmann, Martin Schmidt-Hieber, Johannes Hoffmann, Bettina Zinngrebe, Ulrich Kaiser, Peter Reimer, Robert Möhle, Peter Fix, Heinz-Gert Höffkes, Ulrich Langenkamp, Christian Meyer Zum Büschenfelde, Olaf Hopfer, Andrea Stoltefuß, Paul La Rosée, Henning Blasberg, Karin Jordan, Stephan Kaun, Meike Unteroberdörster, Ann-Christin von Brünneck, David Capper, Frank L. Heppner, Björn Chapuy, Martin Janz, Stefan Schwartz, Frank Konietschke, Peter Vajkoczy, Agnieszka Korfel, Ulrich Keller
Pubblicazione 2023-08-01
Articolo